Covers 10 Types of Cancer Including Breast and Ovarian Cancer

📍Price: HK$1,400 / person
⏱️ Report Time: ~7–10 working days
🙎🏼‍♀️ Result Review: Results clearly explained by GP or medical staff
🩺Process: Registration ➝ Blood draw — 30–45 minutes, no fasting required
🎁Add-on: Add a 35-items health check package for HK$199 at checkout (details at the bottom of this page 👇🏻)please state “Add $199” in the additional column when checking out of your shopping cart online.

Basic Cancer Screening for Women package includes:

1. EBeasy (Epstein-Barr Virus, EBV) – Mainly for Nasopharyngeal Carcinoma
2. CA 15.3 – Breast Cancer
3. CA 125 – Ovarian Cancer, Endometrial (Uterus) cancer
4. CEA – Colon Cancer, Lung Cancer
5. CA 19.9 – Stomach Cancer, Pancreatic Cancer, Gall Bladder / Bile Duct Cancer
6. CA 72.4 – Stomach Cancer, Pancreatic Cancer
7. Alpha Fetoprotein, AFP – Liver Cancer

What is a tumor marker?

A tumor marker is a biomarker found in blood, body tissues, or urine, which can be produced by cancer cells or normal cells in response to cancer in the body.

While some tumor markers are linked to a specific cancer type, others are found in various types of cancers.

Why are they useful?

• Screening for common cancers
• Diagnosis of specific tumour types
• Check if the treatment is effective
• Prognosis
• Monitoring cancer survivors

EB Virus DNA Test

This blood test detects the presence of Epstein-Barr virus (EBV) DNA in the body. Most nasopharyngeal cancer patients in Hong Kong test positive for EBV antibodies, making this one of the most commonly used screening tools for early detection of nasopharyngeal carcinoma.

• A negative result indicates no current EBV infection.
• A positive result suggests EBV infection, and further evaluation with nasoendoscopy is recommended.

CEA – Carcinoembryonic Antigen

CEA is a common tumor marker, particularly for colorectal cancer. However, elevated levels may also occur in patients with lung cancer, breast cancer, thyroid cancer, pancreatic cancer, liver cancer, gastric cancer, ovarian cancer, and bladder cancer.

CA 15.3 – Cancer Antigen 15.3

CA 15.3 is a protein produced by normal breast cells, but elevated levels are often found in patients with breast tumors. This marker enters the bloodstream through tumor cells and is commonly used to monitor the progression and recurrence of breast cancer.

• Higher levels typically correlate with later stages or larger tumor burden.
• The highest levels are often observed in metastatic breast cancer, especially with bone or liver involvement.
• Normal CA 15.3 levels do not rule out early or localized breast cancer and should be used as a supplementary indicator alongside other diagnostics.

CA 125 – Cancer Antigen 125

CA 125 is used to assess the presence and treatment response of ovarian cancer.

• Inherited mutations in the BRCA1 or BRCA2 genes significantly increase ovarian cancer risk.
• Elevated CA 125 may also be seen in non-cancerous conditions (e.g. menstruation, fibroids) and other cancers such as endometrial, peritoneal, and fallopian tube cancer.

CA 19.9 – Cancer Antigen 19.9

While healthy individuals may have low levels of CA 19.9, elevated values are often associated with pancreatic cancer.

• High levels can also indicate other cancers such as bile duct or gallbladder cancer, or benign conditions like cirrhosis.

CA 72.4 – Cancer Antigen 72.4

CA 72.4 is useful in detecting cancers such as pancreatic, colorectal, breast, and ovarian cancer. It is particularly sensitive for gastric cancer, and thus is often used as a reference marker alongside other diagnostic tests.

AFP – Alpha-Fetoprotein

AFP is a protein normally produced in the fetus, with levels dropping after birth.

• Elevated AFP in adults may signal liver cancer, ovarian cancer, testicular cancer, or chronic liver diseases such as hepatitis or cirrhosis.

💼 Who Should Consider This Screening?

✅ Women aged 35 or above
✅ Those with a family history of cancer (e.g., breast, ovarian, nasopharyngeal cancer)
✅ Individuals experiencing persistent fatigue, abnormal weight changes, or irregular menstruation
✅ Women seeking regular preventive health check-ups
✅ Individuals with previously elevated tumor marker results requiring follow-up

📝 Screening Process

📞 Book an appointment online or by phone 2736 6228
🧪 Visit our centre for a simple blood test — no fasting required
📄 Report available in approximately 7–10 working days, explained by a doctor and medical staff

❓ Frequently Asked Questions (FAQ)

Q: Who is this screening suitable for?
A: Women aged 35 and above, those with a family history of cancer, or individuals concerned about breast, ovarian, or nasopharyngeal cancer risks are advised to undergo regular screening.

Q: Do I need to fast before the test?
A: No. You may eat and drink as usual before the screening.

Q: Can the report be used for further medical consultations?
A: Yes. The report is issued by a registered laboratory and signed by a registered doctor, and can be used for medical reference.

📅 Book Your Women’s Cancer Screening Today

We recommend scheduling in advance. Let us help you take proactive steps toward protecting your health.

Booking Procedure

For more details, please click on Check-up items.

More information: 

Medline Plus

Hospital Authority